956 related articles for article (PubMed ID: 16509759)
1. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
Bosch TM; Meijerman I; Beijnen JH; Schellens JH
Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
Bosch TM
Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and cancer chemotherapy.
Iyer L; Ratain MJ
Eur J Cancer; 1998 Sep; 34(10):1493-9. PubMed ID: 9893619
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.
Candelaria M; Taja-Chayeb L; Arce-Salinas C; Vidal-Millan S; Serrano-Olvera A; Dueñas-Gonzalez A
Anticancer Drugs; 2005 Oct; 16(9):923-33. PubMed ID: 16162969
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
Oscarson M
Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
[TBL] [Abstract][Full Text] [Related]
7. An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment.
Ekhart C; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
Cancer Treat Rev; 2009 Feb; 35(1):18-31. PubMed ID: 18771857
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
Bosch TM; Doodeman VD; Smits PH; Meijerman I; Schellens JH; Beijnen JH
Mol Diagn Ther; 2006; 10(3):175-85. PubMed ID: 16771603
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
Serpe L; Canaparo R; Scordo MG; Spina E
Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
[TBL] [Abstract][Full Text] [Related]
10. DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity.
Rumiato E; Boldrin E; Amadori A; Saggioro D
Cancer Chemother Pharmacol; 2013 Aug; 72(2):483-8. PubMed ID: 23760813
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.
Quaranta S; Thomas F
Therapie; 2017 Apr; 72(2):205-215. PubMed ID: 28262261
[TBL] [Abstract][Full Text] [Related]
12. Brief review of polymorphic drug-metabolizing enzymes in Japanese populations: development of a higher-throughput genotyping method and proposed applications.
Kubota T
Drug Metab Lett; 2007 Apr; 1(2):137-42. PubMed ID: 19356033
[TBL] [Abstract][Full Text] [Related]
13. Cancer pharmacogenetics.
Marsh S; McLeod HL
Br J Cancer; 2004 Jan; 90(1):8-11. PubMed ID: 14710198
[TBL] [Abstract][Full Text] [Related]
14. Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
Bertholee D; Maring JG; van Kuilenburg AB
Clin Pharmacokinet; 2017 Apr; 56(4):317-337. PubMed ID: 27641154
[TBL] [Abstract][Full Text] [Related]
15. [Cancer chemotherapy and drug metabolism enzyme].
Xu F; Zhen YS; Shao RG
Sheng Li Ke Xue Jin Zhan; 2005 Oct; 36(4):295-8. PubMed ID: 16408765
[TBL] [Abstract][Full Text] [Related]
16. Inherited variations in drug-metabolizing enzymes: significance in clinical oncology.
Iyer L
Mol Diagn; 1999 Dec; 4(4):327-33. PubMed ID: 10671643
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Hasegawa Y
Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
[TBL] [Abstract][Full Text] [Related]
18. TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy?
Maitland ML; Vasisht K; Ratain MJ
Trends Pharmacol Sci; 2006 Aug; 27(8):432-7. PubMed ID: 16815558
[TBL] [Abstract][Full Text] [Related]
19. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
Stingl JC; Bartels H; Viviani R; Lehmann ML; Brockmöller J
Pharmacol Ther; 2014 Jan; 141(1):92-116. PubMed ID: 24076267
[TBL] [Abstract][Full Text] [Related]
20. Clinical applicability of sequence variations in genes related to drug metabolism.
Stojiljkovic M; Patrinos GP; Pavlovic S
Curr Drug Metab; 2011 Jun; 12(5):445-54. PubMed ID: 21453274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
